LB-S&T-40 EFFECT OF TRPM7 ON APOPTOSIS AND METASTASIS OF BLADDER CANCER VIA MAPK AND PI3K/AKT SIGNALING PATHWAYS

Rui Cao,Tongzu Liu,Zhe Meng,Zhonghua Yang,Yu Xiao,Xinghuan Wang

DOI: https://doi.org/10.1016/j.juro.2016.03.121

2016-01-01

Abstract:You have accessJournal of UrologyLate-Breaking S&T Poster1 Apr 2016LB-S&T-40 EFFECT OF TRPM7 ON APOPTOSIS AND METASTASIS OF BLADDER CANCER VIA MAPK AND PI3K/AKT SIGNALING PATHWAYS Rui Cao, Tongzu Liu, Zhe Meng, Zhonghua Yang, Yu Xiao, and Xinghuan Wang Rui CaoRui Cao , Tongzu LiuTongzu Liu , Zhe MengZhe Meng , Zhonghua YangZhonghua Yang , Yu XiaoYu Xiao , and Xinghuan WangXinghuan Wang View All Author Informationhttps://doi.org/10.1016/j.juro.2016.03.121AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The transient receptor potential melastatin member 7 (TRPM7) is highly related to distinct human malignancies, but its role in bladder cancer is still unknown. Our microarray analysis using bladder cancer tissues compared with normal bladder tissues revealed a close correlation between TRPM7 and bladder cancer via cancer pathways as well as MAPK pathway. The aim of this study was to investigate the molecular mechanism of TRPM7 and related pathways in bladder cancer. METHODS Deficiency of TRPM7 could alter cell growth and proliferation analyzed by MTT test. Using flow cytometer cell cycle arrest and apoptosis were analyzed. Ralted protein abundance were analyzed by Western blot and localization alterations were revealed by immunofluorescence stainings in bladder cancer cells and tissues, suggested by microarray analysis. Using nude mice, effect of TRPM7 deactivation was analyzed by morphological comparision and Western blot. RESULTS Morphological results suggested an overexpression of TRPM7 in human bladder cancer tissues. Knockdown of TRPM7 in bladder cancer cell lines triggered alterations of bladder cancer cell viability, motility and invasion. Results from cell cycle distribution and AnnexinV/PI staining suggested TRPM7 reducing could induce cell cycle arrest and apoptosis in a ERK1/2 mediated mitochondrial-dependent manner. Furthermore, migratory and invasive capabilities of bladder cancer cells lacking TRPM7 were decreased by inactivation of FAK and MMPs through PI3K/AKT pathway. Interestingly, Epithelial-mesenchymal transition (EMT) markers were also affected, indicating reduction of TRPM7 could block induction of EMT and decrease the malignancy of bladder cancer, confirmed by analysis using nude mice. CONCLUSIONS Reducing of TRPM7 could induce bladder cancer cell apoptosis via MAPK pathway, and therefore Trpm7 gene might be a potential clinical biomarker and a therapeutic target in bladder cancer. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e353 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Rui Cao More articles by this author Tongzu Liu More articles by this author Zhe Meng More articles by this author Zhonghua Yang More articles by this author Yu Xiao More articles by this author Xinghuan Wang More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...